GUGGINO, Giuliana
 Distribuzione geografica
Continente #
NA - Nord America 12.050
AS - Asia 4.020
EU - Europa 3.986
SA - Sud America 872
AF - Africa 130
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 21.071
Nazione #
US - Stati Uniti d'America 11.879
SG - Singapore 1.524
CN - Cina 1.287
IT - Italia 1.131
BR - Brasile 710
DE - Germania 516
FI - Finlandia 484
RU - Federazione Russa 484
HK - Hong Kong 468
VN - Vietnam 280
GB - Regno Unito 255
PL - Polonia 224
UA - Ucraina 218
IE - Irlanda 167
SE - Svezia 133
IN - India 90
CA - Canada 88
FR - Francia 80
MX - Messico 62
AR - Argentina 61
NL - Olanda 52
JP - Giappone 46
KR - Corea 43
ZA - Sudafrica 43
AT - Austria 42
RO - Romania 41
TR - Turchia 40
ES - Italia 38
ID - Indonesia 28
IQ - Iraq 28
BD - Bangladesh 27
CI - Costa d'Avorio 27
EC - Ecuador 25
BE - Belgio 22
CZ - Repubblica Ceca 22
IR - Iran 20
EG - Egitto 18
PK - Pakistan 18
AE - Emirati Arabi Uniti 17
CO - Colombia 17
CH - Svizzera 16
KE - Kenya 15
CL - Cile 14
LT - Lituania 13
MY - Malesia 12
PY - Paraguay 12
SA - Arabia Saudita 12
UZ - Uzbekistan 12
VE - Venezuela 12
GR - Grecia 11
MA - Marocco 8
PT - Portogallo 8
AZ - Azerbaigian 7
BO - Bolivia 7
PA - Panama 7
PE - Perù 7
GE - Georgia 6
IL - Israele 6
JO - Giordania 6
NP - Nepal 6
AL - Albania 5
AU - Australia 5
DZ - Algeria 5
LB - Libano 5
PH - Filippine 5
TW - Taiwan 5
UY - Uruguay 5
BG - Bulgaria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
TN - Tunisia 4
BY - Bielorussia 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EU - Europa 3
NZ - Nuova Zelanda 3
AM - Armenia 2
BH - Bahrain 2
HR - Croazia 2
JM - Giamaica 2
LV - Lettonia 2
MD - Moldavia 2
MU - Mauritius 2
OM - Oman 2
RS - Serbia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GH - Ghana 1
GY - Guiana 1
IM - Isola di Man 1
Totale 21.054
Città #
Fairfield 1.656
Ashburn 1.548
Singapore 929
Woodbridge 850
Seattle 742
Houston 703
Chandler 655
Wilmington 642
Cambridge 512
Hong Kong 436
Palermo 355
Ann Arbor 354
Des Moines 248
Beijing 239
Dallas 233
Los Angeles 209
Medford 196
Chicago 189
Zgierz 185
Dublin 166
New York 165
Moscow 162
Altamura 149
The Dalles 129
Princeton 127
Hefei 126
Munich 119
Santa Clara 115
Lawrence 114
Ho Chi Minh City 110
Jacksonville 104
San Diego 104
Nanjing 102
Boardman 84
Helsinki 81
Ludwigshafen am Rhein 68
São Paulo 61
Buffalo 59
London 58
Dearborn 56
Hanoi 53
Jinan 49
Shenyang 43
Tulsa 41
Phoenix 40
Salt Lake City 40
Tokyo 39
Changsha 36
Council Bluffs 36
Nanchang 36
Rome 36
Nuremberg 35
Hebei 33
Jiaxing 33
Tianjin 33
Warsaw 33
Columbus 30
Brooklyn 29
Frankfurt am Main 29
Denver 28
Guangzhou 28
Johannesburg 28
Ningbo 28
San Paolo di Civitate 28
Abidjan 27
Milan 27
Montreal 27
Tampa 27
Falls Church 26
Poplar 26
Ottawa 25
Seoul 25
Rio de Janeiro 24
Central 23
Elk Grove Village 23
Zhengzhou 23
Amsterdam 22
Orem 22
Venice 22
Sterling 21
Brussels 19
Da Nang 19
Stockholm 19
Belo Horizonte 18
Lappeenranta 18
Toronto 18
West Jordan 18
Pune 17
Hangzhou 16
Kilburn 16
Redondo Beach 16
Saint Petersburg 16
Vienna 16
Atlanta 15
Chennai 15
Kumar 15
San Jose 15
Seongnam 15
Ankara 14
Curitiba 14
Totale 14.703
Nome #
Increased percentages of calprotectin and TNF-Α double-positive monocytes in the acute phase of Kawasaki disease 289
Brain Modulation by Electric Currents in Fibromyalgia: A Structured Review on Non-invasive Approach With Transcranial Electrical Stimulation 281
Effectiveness and safety of filgotinib in rheumatoid arthritis: a real-life multicentre experience 255
Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection 246
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 244
The janus face of NKT cell function in autoimmunity and infectious diseases 237
Downregulation of miRNA17-92 cluster marks Vγ9Vδ2 T cells from patients with rheumatoid arthritis 228
Expression of Interleukin-32 in the Inflamed Arteries of Patients With Giant Cell Arteritis 227
Ectopic expression of CXCL13, BAFF, APRIL and LT-ß is associated with artery tertiary lymphoid organs in giant cell arteritis 227
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 226
Predominance of Type 1 Innate Lymphoid Cells in the Rectal Mucosa of Patients With Non-Celiac Wheat Sensitivity: Reversal After a Wheat-Free Diet 220
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis 220
Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18. 219
Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? 216
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity. 216
New insights into the pathogenesis of giant cell arteritis 216
Endothelial progenitor cells: Are they displaying a function in autoimmune disorders? 215
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 212
Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: A prospective open-label study 209
Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis 205
IL-17 polarization of MAIT cells is derived from the activation of two different pathways 203
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis 195
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 195
Granzyme A as a potential biomarker of Mycobacterium tuberculosis infection and disease 193
Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome. 192
IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16+ monocytes 192
IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. 190
Peripheral Frequency of CD4+ CD28- Cells in Acute Ischemic Stroke: Relationship With Stroke Subtype and Severity Markers. 190
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 190
Invariant natural killer T cells treated with rapamycin or transforming growth factor-β acquire a regulatory function and suppress T effector lymphocytes 188
HLA-C1 ligands are associated with increased susceptibility to systemic lupus erythematosus 186
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 184
Brief Report: Functional Interaction of Endoplasmic Reticulum Aminopeptidase 2 and HLA–B27 Activates the Unfolded Protein Response 181
Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis 179
Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome 179
Pro-inflammatory CX3CR1+ CD59+ TL1A+ IL-23+ monocytes are expanded in patients with Ankylosing Spondylitis and modulate ILC3 immune functions 178
Multifunctional CD4+T cells correlate with active Mycobacterium tuberculosis infection 177
Clinical efficacy of α4 integrin block with natalizumab in ankylosing spondylitis 176
Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients. 174
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 172
Timing of activation of CD4+ memory cells as a possible marker to establish the efficacy of vaccines against contagious agalactia in sheep. 171
Tuning inflammation in tuberculosis: the role of decoy receptors 170
Differentiation of human CD8+ T cells in BCG vaccinated and tuberculous patients. 169
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 167
Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients 167
Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis 166
Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue 165
carboxyamidotriazole-orotate inhibits the growth of imatinib resistant chronic myeloid leukaemia cells and modulates exosomes-stimulated angiogenesis 164
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 164
Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens. 162
An intense physical rehabilitation program determines pain relief and improves the global quality of life in patients with fibromyalgia 161
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 160
New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response 159
Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome. 159
The role of the gastrointestinal tract in the pathogenesis of rheumatic diseases 158
ABERRANT EXPRESSION OF IL-22RA1 ON HEMATOPOIETIC CELLS AS IMMUNOLOGICALLY SIGNATURE OF PRIMARY SJOGREN’S SYNDROME AND SJOGREN-ASSOCIATED NON-HODGKIN LYMPHOMAS 152
Interleukin-9 and T helper type 9 cells in rheumatic diseases 152
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. 151
V{gamma}9V{delta}2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells. 148
Predominance of type 1 innate lymphoid cells in the rectal mucosa of patients with non-celiac wheat sensitivity: reversal after a wheat-free diet 148
Pathogenesis of polymyalgia rheumatica 148
Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. 145
Carboxyamidotriazole-orotate inhibits the growth of imatinib-resistant chronic myeloid leukemia cells and modulates exosomes-stimulated angiogenesis 145
Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis 143
T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy 143
Efficacy and safety of γδT cell-based tumor immunotherapy: a meta-analysis. 141
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 140
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome. 139
Genome-based in silico identification of new Mycobacterium tuberculosis antigens activating polyfunctional CD8+ T cells in human tuberculosis. 138
Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients 137
Invariant NKT cells and rheumatic disease: Focus on primary sjogren syndrome 136
HUMAN MEMORY VGAMMA9 VDELTA2 T CELLS REQUIRE HOMEOSTATIC CYTOKINES FOR PROLIFERATION AND DIFFERENTIATION. 131
The in vitro addition of methotrexate and/or methylprednisolone determines peripheral reduction in Th17 and expansion of conventional Treg and of IL-10 producing Th17 lymphocytes in patients with early rheumatoid arthritis. 131
Memory and effector CD8 T cell subset in human tuberculosis. 129
Primary sjogren syndrome: Focus on innate immune cells and inflammation 129
The expanding universe of gamma delta T lymphocytes: subsets, generation and function 126
CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren's syndrome patients and correlates with focus score and disease activity 126
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis 126
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 126
Memory and effector CD8 T cell subsets in human tuberculosis. 125
Optimizing Tumor-Reactive γδ T Cells for Antibody-Based Cancer Immunotherapy 124
Cross-talk between human myeloid dendritic cells and VG9VD2 T cells during M. tuberculosis infection. 124
AUTOPHAGY, BUT NOT THE UNFOLDED PROTEIN RESPONSE, REGULATES THE EXPRESSION OF IL-23 IN THEGUT OF PATIENTS WITH ANKYLOSING SPONDYLITIS AND SUBCLINICAL GUT INFLAMMATION 124
The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome 121
Uncoupling Protein 2 as genetic risk factor for systemic lupus erythematosus: association with malondialdehyde levels and intima media thickness 120
null 118
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 118
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 118
B-Cell Receptor Signaling Is Thought to Be a Bridge between Primary Sjogren Syndrome and Diffuse Large B-Cell Lymphoma 117
Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome 117
Histopathology of the gut in rheumatic diseases 117
Interstitial lung disease in systemic sclerosis: current and future treatment 116
Cardiovascular disease in primary sjögren’s syndrome 116
Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion 115
Subclinical and clinical atherosclerosis in rheumatoid arthritis: Results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 115
Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome 113
Gut-derived CD8+ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients 110
Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells 110
Interstitial Lung Disease in Elderly Rheumatoid Arthritis Patients 110
Cell Immunity in Inflammatory Vasculitis 109
Totale 16.571
Categoria #
all - tutte 88.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.143


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.446 0 0 0 0 0 196 179 175 185 308 216 187
2021/20221.674 108 319 45 63 39 92 92 120 204 230 112 250
2022/20232.240 214 433 55 201 233 293 203 177 264 18 106 43
2023/20241.205 64 145 62 73 92 302 163 66 27 39 38 134
2024/20253.546 76 218 206 220 119 179 245 239 265 339 563 877
2025/20265.010 768 318 862 1.081 1.280 701 0 0 0 0 0 0
Totale 22.485